You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 4, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Flurbiprofen or Prednisolone

Effect on Corneal Wound Healing in Rabbits

David Miller, MD; Peter Gruenberg, MD; Roger Miller; Michael V. W. Bergamini, PhD

Arch Ophthalmol. 1981;99(4):681-682.


Abstract

• Flurbiprofen is a nonsteroidal anti-inflammatory (NSAI) agent currently undergoing clinical investigation. Anti-inflammatory steroids have long been known to delay the healing of corneal stromal wounds. This study was designed to compare the effects of equipotent anti-inflammatory doses of flurbiprofen and of prednisolone acetate on the inflammation and the healing (as measured by the wound bursting pressure) of 4-mm through-and-through incisions treated four times a day for ten postoperative days. The results suggest that flurbiprofen and prednisolone are not different in their effect on both postoperative inflammation and postoperative wound healing. Since NSAI agents and steroids inhibit prostaglandin formation at different enzymatic steps, it is possible that prostaglandins not only are responsible for postoperative inflammation but also are required for postoperative wound healing.



Author Affiliations

From, the Department of Ophthalmology, Beth Israel Hospital, Harvard Medical School, Boston (Drs Miller and Gruenberg and Mr Miller), and the Pharmacology Section, Allergan Pharmaceuticals, Irvine, Calif (Dr Bergamini).


Footnotes

Accepted for publication June 24, 1980.

Read in part before the Association for Research in Vision and Ophthalmology, Orlando, Fla, May 5, 1980.

Reprint requests to Department of Ophthalmology, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Miller)



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Keratocyte Loss After Corneal Deepithelialization in Rabbits
Nassaralla et al.
Arch Ophthalmol 1995;113:506-511.
ABSTRACT  

Topical Nonsteroidal Agents and Corneal Wound Healing
Hersh et al.
Arch Ophthalmol 1990;108:577-583.
ABSTRACT  

The Histopathology of Corneal Neovascularization: Inhibitor Effects
Robin et al.
Arch Ophthalmol 1985;103:284-287.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.